ASGO Education shared a post on X:
“Dear all, The ASGO Journal Club presents an insightful session titled “Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.” “
Read for further details.